Macrolide-Resistant Mycoplasma pneumoniae in Humans, Ontario, Canada, 2010-2011

被引：47

作者：

Eshaghi, AliReza ^{[1
]}

Memari, Nader ^{[1
]}

Tang, Patrick ^{[1
]}

Olsha, Romy ^{[1
]}

Farrell, David J. ^{[1
,2
]}

Low, Donald E. ^{[1
,2
,3
]}

Gubbay, Jonathan B. ^{[1
,2
,3
,4
]}

Patel, Samir N. ^{[1
,2
]}

机构：

[1] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada

[2] Univ Toronto, Toronto, ON, Canada

[3] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada

[4] Hosp Sick Children, Toronto, ON M5G 1X8, Canada

来源：

EMERGING INFECTIOUS DISEASES | 2013年 / 19卷 / 09期

关键词：

MOLECULAR ANALYSIS; IN-VITRO; INFECTION; STRAINS; HOMINIS; FRANCE; GENE;

D O I：

10.3201/eid1909.121466

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011-2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11(12.1%) carried nucleotide mutations associated with macrolide resistance in the 23S rRNA gene. None of the M. pneumonia specimens were resistant to fluoroquinolones or tetracyclines.

引用

页码：1525 / 1527

页数：3

共 15 条

[1]

Averbuch D, 2011, EMERG INFECT DIS, V17, P1079, DOI [10.3201/eid1706.101558, 10.3201/eid/1706.101558]

[2]

Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]

[3] High Prevalence of Macrolide Resistance in Mycoplasma pneumoniae Isolates from Adult and Adolescent Patients with Respiratory Tract Infection in China [J].

Cao, Bin ;

Zhao, Chun-Jiang ;

Yin, Yu-Dong ;

Zhao, Fei ;

Song, Shu-Fan ;

Bai, Lu ;

Zhang, Jian-Zhong ;

Liu, Ying-Mei ;

Zhang, Yu-Yu ;

Wang, Hui ;

Wang, Chen .

CLINICAL INFECTIOUS DISEASES, 2010, 51 (02) :189-194

[4] Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae [J].

Degrange, S. ;

Renaudin, H. ;

Charron, A. ;

Pereyre, S. ;

Bebear, C. ;

Bebear, C. M. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (06) :1390-1392

[5] Mycoplasma pneumoniae P1 type 1-and type 2-specific sequences within the P1 cytadhesin gene of individual strains [J].

Dorigo-Zetsma, JW ;

Wilbrink, B ;

Dankert, J ;

Zaat, SAJ .

INFECTION AND IMMUNITY, 2001, 69 (09) :5612-5618

[6] Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany [J].

Dumke, R. ;

von Baum, H. ;

Lueck, P. C. ;

Jacobs, E. .

CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (06) :613-616

[7] In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively [J].

Gruson, D ;

Pereyre, S ;

Renaudin, H ;

Charron, A ;

Bébéar, C ;

Bébéar, CM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) :1190-1193

[8] A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients [J].

Matsubara, Keita ;

Morozumi, Miyuki ;

Okada, Takafumi ;

Matsushima, Takahiro ;

Komiyama, Osamu ;

Shoji, Michi ;

Ebihara, Takashi ;

Ubukata, Kimiko ;

Sato, Yoshitake ;

Akita, Hironobu ;

Sunakawa, Keisuke ;

Iwata, Satoshi .

JOURNAL OF INFECTION AND CHEMOTHERAPY, 2009, 15 (06) :380-383

[9] Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan [J].

Matsuoka, M ;

Narita, M ;

Okazaki, N ;

Ohya, H ;

Yamazaki, T ;

Ouchi, K ;

Suzuki, I ;

Andoh, T ;

Kenri, T ;

Sasaki, Y ;

Horino, A ;

Shintani, M ;

Arakawa, Y ;

Sasaki, T .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4624-4630

[10] Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia [J].

Morozumi, Miyuki ;

Iwata, Satoshi ;

Hasegawa, Keiko ;

Chiba, Naoko ;

Takayanagi, Reiko ;

Matsubara, Keita ;

Nakayama, Eiichi ;

Sunakawa, Keisuke ;

Ubukata, Kimiko .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (01) :348-350

← 1 2 →